Topical Compositions

A synergistic blend of 1,4-di(benzoxazol-2'-yl)benzene with hydroxyacetophenones, alkanediols, and benzoic acid improves antimicrobial efficacy in cosmetic compositions, addressing the need for reduced preservatives while maintaining product safety and longevity.

JP7582751B2Active Publication Date: 2024-11-13DSM IP ASSETS BV
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
JP2022510129
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2019-09-11
Filing Date
2020-08-26
Publication Date
2024-11-13
Estimated Expiration
2040-08-26

AI Technical Summary

Technical Problem

There is a need for alternative preservatives in cosmetic compositions that reduce microbial growth without compromising safety and shelf life, as public concern over traditional preservatives is high, particularly in products with high water content like creams and lotions.

Method used

A synergistic mixture of 1,4-di(benzoxazol-2'-yl)benzene with hydroxyacetophenones, alkanediols, and benzoic acid or its salts is used to enhance antimicrobial activity, reducing the need for traditional preservatives while maintaining effectiveness.

Benefits of technology

The mixture demonstrates enhanced antimicrobial properties, effectively inhibiting a wide range of bacteria and fungi, thereby extending the shelf life and ensuring consumer safety of cosmetic products.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007582751000001
    Figure 0007582751000001
  • Figure 0007582751000002
    Figure 0007582751000002
  • Figure 0007582751000003
    Figure 0007582751000003
Patent Text Reader

Abstract

The present invention relates to cosmetic compositions comprising a mixture of 1,4-di(benzoxazol-2'-yl)benzene and a preservative, and the use of said mixture as an antimicrobial agent.
Need to check novelty before this filing date? Find Prior Art

Description

Detailed Description of the Invention

[0001] The present invention relates to cosmetic compositions comprising a mixture of 1,4-di(benzoxazol-2'-yl)benzene and a preservative and the use of said mixture as an antimicrobial agent.

[0002] Microorganisms are responsible for the spoilage of everyday products such as food and cosmetics. Reducing microbial growth is therefore essential not only to improve the shelf life (storage stability) of the product itself, but also to ensure consumer safety. Accordingly, preservatives are generally added to the respective products. However, due to the strong social controversy surrounding the use of certain preservatives, options that allow reducing or even avoiding this type of agent are highly desirable in industry, especially in the cosmetics industry. This is because topical compositions such as creams and lotions have a relatively high water content and are particularly susceptible to attack by microorganisms. Therefore, there is a continuing need for alternatives that help prevent changes over time while preserving the safety of cosmetic formulations.

[0003] Surprisingly, it has now been found that 1,4-di(benzoxazol-2'-yl)benzene can synergistically improve the antimicrobial activity of preservatives (often referred to as antimicrobial agents) commonly used in cosmetic compositions.This surprising discovery is highly advantageous, since it allows the amount of preservatives in cosmetic compositions to be reduced, while still maintaining the antimicrobial properties necessary to ensure adequate shelf life and consumer safety.

[0004] Thus, in a first embodiment, the present invention relates to a topical composition comprising 1,4-di(benzoxazol-2'-yl)benzene and at least one compound selected from the group of hydroxyacetophenones, alkanediols, and benzoic acid or a salt thereof.

[0005] In a second embodiment, the present invention relates to the use of a mixture of 1,4-di(benzoxazol-2'-yl)benzene and at least one compound selected from the group of hydroxyacetophenones, alkanediols, and benzoic acid or its salts as a synergistic antimicrobial mixture (preservative booster).

[0006] In a third embodiment, the present invention relates to the use of a mixture of 1,4-di(benzoxazol-2'-yl)benzene and at least one compound selected from the group of hydroxyacetophenones, alkanediols, and benzoic acid or its salts, as an antimicrobial agent, i.e. an agent exhibiting antimicrobial activity, in particular for improving the shelf life and / or storage stability of a topical composition.

[0007] In particular, the present invention relates to the use of a mixture of 1,4-di(benzoxazol-2'-yl)benzene with at least one compound selected from the group consisting of hydroxyacetophenones, alkanediols, and benzoic acid or a salt thereof, as an antifungal and / or antibacterial agent, more particularly against fungi, in particular yeasts or molds and / or bacteria (gram-positive and / or gram-negative), most preferably Escherichia Coli (E. Coli), Pseudomonas aeruginosa (P. aeruginosa), Staphylococcus aureus (S. aureus), Aspergillus brasiliensis (A. brasiliensis), and / or Candida albicans (Candida albicans). The present invention relates to the use of an antibacterial agent for killing and / or inhibiting the growth of C. albicans, C. albicans, and mixtures thereof, particularly for improving the shelf life and / or storage stability of topical compositions.

[0008] In a further embodiment, the present invention relates to a method for killing and / or inhibiting the growth of microbial cells, in particular fungal such as yeast or mold and / or bacterial cells, most particularly Escherichia coli (E. Coli), Pseudomonas aeruginosa (P. aeruginosa), Staphylococcus aureus (S. aureus), Aspergillus brasiliensis (A. brasiliensis), and / or Candida albicans (C. albicans), and mixtures thereof, said method comprising contacting said microbial cells with a mixture of 1,4-di(benzoxazol-2'-yl)benzene and at least one compound selected from the group of hydroxyacetophenones, alkanediols, and benzoic acid or a salt thereof.

[0009] In another embodiment, the present invention relates to a method for inhibiting or slowing microbial degradation of a topical composition, comprising adding to the topical composition an effective amount of 1,4-di(benzoxazol-2′-yl)benzene and at least one compound selected from the group of hydroxyacetophenones, alkanediols, and benzoic acid or a salt thereof.

[0010] The term "effective amount" as used herein refers to the amount required to obtain the desired antimicrobial effect. Of course, the effective amount may vary depending on known factors, particularly the details of cosmetic formulations, but those skilled in the art can adjust it within the range of amounts and ratios specified herein.

[0011] As used herein, the term "antimicrobial activity" (or "antimicrobial effect") refers to the antimicrobial activity of microbial cells, particularly bacteria and fungal cells (especially molds and / or yeasts), such as Propiobacterium acnes (P. acnes), Staphylococcus epidermis (S. epidermis), Malassezia furfur (M. furfur), Aspergillus brasiliensis (A. brasiliensis), Escherichia coli (E. Coli), Pseudomonas aeruginosa (P. aeruginosa), Staphylococcus aureus (S. aureus), and the like. , Aspergillus brasiliensis, and / or Candida albicans, and mixtures thereof, however preferably Escherichia coli (E. Coli), Pseudomonas aeruginosa, Staphylococcus aureus (S. aureus), Aspergillus brasiliensis, and / or Candida albicans, and mixtures thereof.

[0012] 1,4-Di(benzoxazol-2'-yl)benzene [CAS 904-39-2] is a colourless to pale yellow solid and can be prepared, for example, as outlined in WO200239972 or as illustrated in the Examples.

[0013] Due to its low solubility, 1,4-di(benzoxazol-2'-yl)benzene is preferably used in finely divided form, ie in the form of solid particles having an average particle size of less than 1 μm, in all embodiments of the present invention.

[0014] In a particularly advantageous embodiment, the average particle size of said micronized form is at most 300 nm. More preferably, the micronized 1,4-di(benzoxazol-2'-yl)benzene has an average particle size in the range of 50 to 300 nm, more preferably in the range of 100 to 300 nm, most preferably in the range of 120 to 280 nm, for example in a range selected from the range of 140 to 240 nm or the range of 150 to 220 nm.

[0015] As used herein, the term "average particle size" refers to the number-based mean particle size distribution D as determined by laser diffraction, e.g., using a Malvern Mastersizer 2000. n 50(D n 0.5) (ISO 13320:2009).

[0016] Micronized 1,4-di(benzoxazol-2'-yl)benzene according to the present invention can be prepared by standard micronization methods in the art, such as those outlined in WO 9522959 and WO 9703643, the specifications of which are incorporated herein by reference.

[0017] The micronized 1,4-di(benzoxazol-2'-yl)benzene according to the invention can be used in powder form or as a dispersion thereof.

[0018] The micronized 1,4-di(benzoxazol-2'-yl)benzene according to the invention may further be in crystalline or solid amorphous form. In all embodiments of the invention, the micronized 1,4-di(benzoxazol-2'-yl)benzene is preferably in solid amorphous form.

[0019] The term "solid amorphous form" as used herein refers to solid particles formed by rapid solid phase formation / separation from a liquid phase in solution or mixture such that the solid is not given time to selectively form a crystalline network, thus resulting in a solid that is primarily in a disordered form (also referred to herein as "solid amorphous 1,4-di(benzoxazol-2'-yl)benzene"). This form can be clearly identified by XRPD analysis by the lack of baseline separation of the peaks between 25-28° 2θ (Cu Kα radiation) when measured using a Bruker D8 Advance Powder X-ray Diffractometer with a LynxEye detector and Cu Kα radiation in reflection (Bragg-Brentano) geometry.

[0020] The solid amorphous form of 1,4-di(benzoxazol-2'-yl)benzene according to the present invention is preferably prepared by a process comprising the steps of: (1) reacting terephthalic acid and 2-aminophenol to produce 1,4-di(benzoxazol-2'-yl)benzene; and (2) precipitating the resulting 1,4-di(benzoxazol-2'-yl)benzene, preferably in the presence of (ice) water, to obtain solid amorphous 1,4-di(benzoxazol-2'-yl)benzene, which in a subsequent step is micronized according to methods standard in the art. This process may optionally include an intermediate purification step. Alternatively, the solid amorphous 1,4-di(benzoxazol-2'-yl)benzene may be further purified by washing with a solvent in which 1,4-di(benzoxazol-2'-yl)benzene is poorly or completely soluble, for example, but not limited to, an alcohol, such as toluene and / or 1-butanol.

[0021] In all embodiments of the present invention, micronized 1,4-di(benzoxazol-2'-yl)benzene is further advantageously used in the form of its aqueous dispersion, since it can be easily incorporated into the topical composition.

[0022] The amount of 1,4-di(benzoxazol-2'-yl)benzene in this type of aqueous dispersion is preferably selected from the range of 10 to 90 mass%, 20 to 80 mass%, or 30 to 70 mass%, more preferably from the range of 25 to 60 mass%, and most preferably from the range of 25 to 55 mass%, for example, from the range of 25 to 50 mass%, the range of 25 to 40 mass%, or the range of 25 to 35 mass%, based on the total mass of the aqueous dispersion.

[0023] The aqueous dispersion may further contain one or more additives, for example to facilitate micronization and / or to stabilize the aqueous dispersion, for example against settling.

[0024] When one or more types of additives are present in the aqueous dispersion, the (total) amount thereof is selected from the range of preferably 0.01 to 25 mass%, more preferably 0.1 to 20 mass%, and most preferably 0.5 to 15 mass%, for example, 1 to 10 mass%, based on the total mass of the aqueous dispersion.

[0025] In all embodiments according to the invention, the at least one additive is preferably selected from the group of surface-active components, in particular nonionic, amphoteric and cationic surfactants, antifoaming agents, salts, wetting agents and thickeners, and mixtures thereof.

[0026] Particularly suitable surface-active components for use in the aqueous dispersions are those of the general formula C n H 2+n O(CH 10 O5) x H, where n is an integer selected from the range of 2 to 22, and x represents the average degree of polymerization of the glucosidic moieties (mono-, di-, tri-, oligo-, and polyglucosides). This type of alkyl polyglucoside is, for example, commercially available from Shanghai Fine Chemical under the trade name Green APG 0810 (containing glucose derived from corn and C8 and C9 from coconut oil and palm kernel oil). 10 C made from fatty alcohols 8~10% (alkyl polyglucoside) or Plantacare 1200 UP (C12-C16 fatty alcohol polyglycoside) from BASF. If a surface-active component is present, it is preferably used in a (total) amount selected from the range of 1 to 20% by weight, more preferably from the range of 5 to 15% by weight, most preferably from the range of 7 to 12.5% ​​by weight, based on the total weight of the aqueous dispersion.

[0027] Particularly suitable defoamers for use in the aqueous dispersion are silicone oils, in particular polydimethylsiloxanes, and / or silicon defoamers, in particular anhydrous dispersions of pyrogenic or hydrophobized silica in silicone oils. Most preferably, the defoamer is simethicone. When this type of defoamer is present, it is preferably used in a (total) amount selected from the range of 0 to 1% by weight, more preferably in an amount of 0.01 to 0.2% by weight, based on the total weight of the aqueous dispersion.

[0028] Salts suitable for use in the aqueous dispersion include alkali and alkaline earth salts of phosphates, hydroxides such as disodium hydrogen phosphate and / or sodium hydroxide, etc. When present, the salt or mixtures thereof are preferably used in an amount (total) of 0.01 to 5% by weight, more preferably 0.1 to 4% by weight, most preferably 0.5 to 2.5% by weight, based on the total weight of the aqueous dispersion.

[0029] Particularly suitable thickeners for use in the aqueous dispersion include xanthan gum, gellan gum, and / or carboxymethylcellulose. Most preferably, the thickener is xanthan gum or gellan gum. If present, this type of thickener is preferably used in a (total) amount selected from the range of 0.1 to 1% by weight, more preferably from the range of 0.1 to 0.5% by weight, based on the total weight of the aqueous dispersion.

[0030] Particularly suitable humectants for use in the aqueous dispersion are (poly)propylene glycols, such as most preferably propylene glycol, which, if present, are preferably selected in an amount ranging from 0.1 to 1% by weight, more preferably from 0.2 to 0.6% by weight, based on the total weight of the aqueous dispersion.

[0031] In all embodiments according to the present invention, preferably an aqueous dispersion is used which consists essentially of finely divided 1,4-di(benzoxazol-2'-yl)benzene, water, and optionally at least one additive, having all the definitions and priorities given herein.

[0032] More preferably, the aqueous dispersion comprises: (i) 25 to 60% by weight, preferably 25 to 50% by weight, of finely divided 1,4-di(benzoxazol-2'-yl)benzene having all the definitions and priorities given herein, based on the total weight of the aqueous dispersion; (ii) C 8~16 alkyl polyglucoside, in an amount of 5 to 15 mass %, preferably 7 to 12.5 mass %, based on the total mass of the aqueous dispersion; (iii) at least one additive selected from the group consisting of thickeners, wetting agents, and / or antifoaming agents, in an amount of 0 to 3 mass %, preferably 0 to 2.5 mass %, based on the total mass of the aqueous dispersion; (iv) water in an amount that totals 100% by mass, based on the total mass of the aqueous dispersion; Basically it consists of:

[0033] The term "consisting essentially of" as used in accordance with the present invention means that the sum of the amounts of components (i) to (iv), adjusted with the amount of water (iv), equals 100% by mass. However, this does not exclude the possible presence of small amounts of impurities or additives, for example, introduced via the respective sources of the components.

[0034] Most advantageously, the aqueous dispersion comprises as additive (iii) propylene glycol and one thickening agent selected from xanthan gum or gellan gum, and optionally simethicone.

[0035] In all embodiments of the invention, the topical composition preferably comprises 1,4-di(benzoxazol-2'-yl)benzene in an amount selected from the range of about 0.1 to 20% by weight, more preferably from about 0.25 to 15% by weight, most preferably from about 0.3 to 10% by weight, for example from about 0.3 to 7.5% by weight, based on the total weight of the composition (and always based on the active substance). Further suitable ranges include 0.25 to 10% by weight, 0.25 to 7.5% by weight, 0.25 to 5% by weight, 1 to 7.5% by weight, and 1 to 5% by weight.

[0036] The term hydroxyacetophenone refers to o-, m- or p-hydroxyacetophenone. In all embodiments of the present invention, p-hydroxyacetophenone [CAS 99-93-4], also referred to as 1-(4-hydroxyphenyl)-ethanone and commercially available, for example, as SymSave® H from Symrise, is particularly preferred.

[0037] In all embodiments of the present invention, the topical composition preferably contains hydroxyacetophenone in an amount selected from the range of 0.001 to 5% by weight, more preferably 0.01 to 4% by weight, and most preferably 0.1 to 3% by weight, based on the total weight of the composition, more preferably 0.005 to 4.5% by weight, 0.05 to 4% by weight, and 0.25 to 3% by weight, based on the total weight of the composition.

[0038] Alkanediols, especially linear and branched C 1~10Alkanediols and the like are well known as preservative enhancers used in cosmetic applications. Particularly suitable alkanediols according to the present invention include linear 1,2-, 1,3-, or 1,4-alkanediols containing about 2 to about 10 carbon atoms, for example, about 3 to about 8 carbon atoms or about 3 to about 7 carbon atoms, in particular 1,2-propanediol, 1,3-propanediol, 1,4-butanediol, 1,2-pentanediol, 1,2-hexanediol, 1,2-octanediol, and 1,2-decanediol. In all embodiments of the present invention, the most preferred alkanediol is 1,3-propanediol [CAS 504-63-2], which is commercially available, for example, under the trade name Zemea™ Propandiol from DuPont Tate & Lyle Bioproducts.

[0039] In all embodiments of the present invention, the topical composition comprises the alkanediol in an amount selected from the range of 0.01 to 6% by weight, more preferably 0.1 to 5% by weight, most preferably 0.5 to 4% by weight, based on the total weight of the composition, more preferably 0.5 to 3.5% by weight or 0.5 to 3% by weight, based on the total weight of the composition.

[0040] Benzoic acid as well as its salts are known preservatives commonly used in food, pharmaceutical and cosmetic products. Preferred salts are potassium or sodium salts, most preferably sodium salts. In all embodiments of the present invention, it is particularly preferred to use benzoic acid [CAS 65-85-0] and / or sodium benzoate [CAS 532-32-1], most preferably sodium benzoate, e.g. available under the trade name Purox® S Grains from Emerald Kalama Chemicals.

[0041] In all embodiments of the present invention, the topical composition preferably comprises benzoic acid or a salt thereof in an amount selected from the range of 0.001 to 6% by weight, more preferably from the range of 0.01 to 4% by weight, and most preferably from the range of 0.1 to 3% by weight, based on the total weight of the composition. Further suitable ranges include 0.1 to 1% by weight and 0.1 to 0.8% by weight, based on the total weight of the composition.

[0042] The mass ratio of 1,4-di(benzoxazol-2'-yl)benzene to at least one compound selected from the group consisting of hydroxyacetophenone, alkanediol, and benzoic acid or a salt thereof is preferably selected from the range of 40:1 to 1:40, more preferably from the range of 30:1 to 1:30, even more preferably from the range of 20:1 and 1:20, for example, from the range of 15:1 to 1:15 or 15:1 to 1:10.

[0043] Most preferably, in the case of hydroxyacetophenone, the mass ratio is selected in the range of 30:1 to 1:2, for example, in the range of 25:1 to 1:1.

[0044] Most preferably, in the case of alkanediol, the mass ratio is selected in the range of 15:1 to 1:5, for example, 10:1 to 1:1:3.

[0045] Most preferably, in the case of benzoic acid or a salt thereof, the mass ratio is selected from the range of 30:1 to 1:1, more preferably from the range of 25:1 to 1:1.

[0046] In all embodiments, the mass ratio of 1,4-di(benzoxazol-2'-yl)benzene to at least one compound selected from the group of hydroxyacetophenone, alkanediol, and benzoic acid or a salt thereof is preferably ≧0.5, more preferably ≧0.75, and most preferably ≧1.

[0047] When the compound is selected from hydroxyacetophenone and / or benzoic acid or a salt thereof, it is also advantageous to use 1,4-di(benzoxazol-2'-yl)benzene in excess, i.e. in excess of the amount of hydroxyacetophenone and / or benzoic acid or a salt thereof, for example such that the mass ratio is greater than 1, more preferably such that the mass ratio is at least 1.25, and most preferably such that the mass ratio is at least 2.

[0048] Mixtures of 1,4-di(benzoxazol-2'-yl)benzene and at least one compound selected from the group of hydroxyacetophenones, alkanediols, and benzoic acid or its salts can be used in a variety of formulations, such as lotions, creams, or gels, to take advantage of their synergistic antimicrobial activity.

[0049] The amount of 1,4-di(benzoxazol-2'-yl)benzene used according to the present invention is preferably selected from the range of 0.1 to 20% by weight, more preferably from about 0.25 to 15% by weight, most preferably from about 0.5 to 10% by weight, for example from 0.3 to 7.5% by weight (all based on the active substance). Further suitable ranges include 0.25 to 10% by weight, 0.25 to 7.5% by weight, 0.25 to 5% by weight, 1 to 7.5% by weight, and 1 to 5% by weight.

[0050] The use according to the invention can on the one hand be a technical use, for example to reduce or prevent microbial growth in a topical composition, for the purpose of improving shelf life and / or storage stability, optionally including a step of evaluating its effectiveness in comparison with a respective product that does not contain 1,4-di(benzoxazol-2'-yl)benzene.

[0051] On the other hand, the use according to the invention of the mixture of 1,4-di(benzoxazol-2'-yl)benzene with at least one compound selected from the group of hydroxyacetophenones, alkanediols, and benzoic acid or its salts can be carried out in a cosmetic or pharmaceutical sense. As a pharmaceutical use, for example, use in the case of certain antimicrobial therapies is envisaged. As a cosmetic use, for example, one aimed at maintaining a healthy homeostasis of the skin and / or balancing the skin microflora by reducing the number of undesirable microorganisms, such as Coli, Pseudomonas aeruginosa, Staphylococcus aureus, Aspergillus brasiliensis, and / or C.albicans, on the skin is envisaged.

[0052] In all embodiments of the invention, the use is preferably a technical and / or cosmetic (non-therapeutic) use.

[0053] Topical compositions according to the invention are preferably cosmetic, dermatological or pharmaceutical compositions that are applied topically to mammalian keratinous tissue, in particular to human skin or the human scalp and hair, etc. Particularly preferred topical compositions in all embodiments of the invention are cosmetic compositions.

[0054] The term "cosmetic composition" as used in this application refers to cosmetic compositions as defined in the "Kosmetika" section of Rompp Lexikon Chemie, 10th edition 1997, Georg Thieme Verlag Stuttgart, New York, and in A. Domsch, "Cosmetic Compositions", Verlag für chemische Industrie (ed. H. Ziolkowsky), 4 th It refers to the cosmetic compositions disclosed in the 1992 edition.

[0055] The topical composition according to the invention preferably further comprises a physiologically acceptable medium, i.e. a medium that is compatible with the skin, mucous membranes and keratinous materials such as keratinous fibers. Preferably, the physiologically acceptable medium is a cosmetically acceptable carrier.

[0056] The term cosmetically acceptable carrier refers in particular to any carrier and / or excipient and / or diluent commonly used in cosmetic compositions, such as oils (cosmetic oils), water, surfactants, emulsifiers, thickeners, etc.

[0057] Topical compositions according to the present invention are generally prepared by mixing 1,4-di(benzoxazol-2'-yl)benzene with at least one compound selected from the group of hydroxyacetophenones, alkanediols, and benzoic acid or salts thereof, in the amounts indicated herein, together with a suitable carrier.

[0058] The exact amount of carrier will depend on the actual amounts of 1,4-di(benzoxazol-2'-yl)benzene, at least one compound selected from the group of hydroxyacetophenone, alkanediol, and benzoic acid or a salt thereof, and other optional ingredients (e.g., other active ingredients) that one of skill in the art would classify as distinct from the carrier.

[0059] In an advantageous embodiment, the cosmetic or pharmaceutical composition according to the present invention comprises a carrier in an amount of about 50% to about 99%, preferably about 60% to about 98%, more preferably about 70% to about 98%, particularly about 80% to about 95%, based on the total mass of the cosmetic composition.

[0060] In a particularly advantageous embodiment, the carrier further comprises at least 40% by weight water, more preferably at least 50% by weight, most preferably at least 55% by weight, such as from about 55 to about 90% by weight.

[0061] The compositions of the present invention (including the carrier) may contain conventional adjuvants and additives such as preservatives / antioxidants, fatty substances / oils, organic solvents, silicones, thickeners, emollients, emulsifiers, antifoaming agents, aesthetic ingredients such as fragrances, surfactants, fillers, anionic, cationic, nonionic or amphoteric polymers or mixtures thereof, propellants, acidifying or basifying agents, dyes, coloring / colorants, abrasives, absorbents, chelating and / or sequestering agents, essential oils, skin fresheners, astringents, pigments, or any other ingredient normally incorporated into such compositions.

[0062] According to the present invention, the composition according to the present invention may also contain further cosmetic active ingredients conventionally used in cosmetic or pharmaceutical compositions.Exemplary active ingredients include skin lightening agents; UV filters; agents for treating hyperpigmentation; agents for preventing or reducing inflammation; firming agents, moisturizing agents, soothing agents, and / or revitalizing agents, and agents for improving elasticity and skin barrier.

[0063] Examples of cosmetic excipients, diluents, adjuvants, additives, and active ingredients commonly used in the skin care industry that are suitable for use in the cosmetic compositions of the present invention are, for example, but not limited to, those listed in the International Cosmetic Ingredient Dictionary & Handbook by the Personal Care Product Council (http: / / www.personalcarecouncil.org / ), available from the online INFO BASE (http: / / online.personalcarecouncil.org / jsp / Home.jsp).

[0064] The required amounts of active ingredients and excipients, diluents, adjuvants, additives, etc. can be readily determined by one skilled in the art based on the desired product form and application. Additional ingredients can be added either to the oily phase, to the aqueous phase, or separately, as deemed appropriate.

[0065] The cosmetically active ingredients useful herein can in some cases provide more than one benefit or operate via more than one mechanism of action.

[0066] Of course, the skilled person will select the above-mentioned optional additional components, adjuvants, diluents and additives and / or their amounts, taking into account that the advantageous properties inherently associated with the combination according to the invention are not adversely affected or are not substantially adversely affected by the addition or additions envisaged.

[0067] Preferably, the topical composition according to the invention is in the form of a suspension or dispersion in a solvent or fatty substance, or in the form of an emulsion or microemulsion (in particular of the O / W or W / O type), a PIT emulsion, a nanoemulsion, a multiple emulsion (for example of the O / W / O or W / O / W type), a Pickering emulsion, a hydrogel, a lipogel, a single- or multiphase solution, or a vesicle dispersion.

[0068] In a preferred embodiment, the cosmetic composition according to the invention is an emulsion and / or a gel. More preferably, the topical composition is an emulsion comprising an oily phase and an aqueous phase, in particular an O / W, W / O, Si / W, W / Si, O / W / O, W / O / W multiple or Pickering emulsion.

[0069] The amount of oily phase (i.e. the phase containing all fats and oils, including polar oils) present in this type of emulsion is preferably at least 10% by weight, for example in the range of 10 to 60% by weight, preferably 15 to 50% by weight, most preferably in the range of 15 to 40% by weight, based on the total weight of the topical composition.

[0070] The amount of aqueous phase present in such emulsions is preferably at least 20% by weight, for example in the range of 20 to 90% by weight, preferably in the range of 30 to 80% by weight, and most preferably in the range of 30 to 70% by weight, based on the total weight of the topical composition.

[0071] Topical compositions according to the present invention may be in the form of a liquid, a lotion, a thickened lotion, a gel, a cream, a milk, an ointment, or a paste.

[0072] The pH of the topical composition according to the present invention is in the range of 3 to 10, preferably in the range of pH 3 to 8, and most preferably in the range of pH 3 to 7.5. The pH is adjusted by methods known to those skilled in the art, for example by using acids, such as hydroxy acids including glycolic acid, lactic acid, malic acid, citric acid, and tartaric acid, or bases, such as sodium or potassium hydroxide or ammonium hydroxide and mixtures thereof.

[0073] Preferably, in the composition according to the invention, the acid or base (if present) is used in an amount of at least 0.0001% by weight, such as for example from 0.01 to 1% by weight, in particular from 0.01 to 0.5% by weight.

[0074] The topical composition according to the invention may contain additional preservatives or preservative enhancers. Particularly suitable preservatives or preservative enhancers in all embodiments of the invention are sorbic acid, potassium sorbate, dehydroacetic acid, caprylhydroximic acid, alcohol, denatured alcohol, monoglycerides such as glyceryl laurate, propylene glycol caprylate, propylene glycol heptanoate, and mixtures thereof. When additional preservatives and / or preservative enhancers are present, they are preferably used in an amount of 0.01 to 2% by weight, more preferably 0.05 to 1.5% by weight, and most preferably 0.1 to 1.0% by weight, based on the total weight of the composition.

[0075] More preferably, the topical composition according to the present invention is free of parabens, benzethonium chloride, piroctone olamine, lauroylarginat, methylisothiazolinone, chloromethylisothiazolinone, bronopol, benzalkonium chloride, formaldehyde releasing compounds, salicylic acid, triclosan, DMDM ​​hydantoin, chlorphenesin, and IPBC (iodopropynyl butylcarbamate).

[0076] More preferably, the topical composition according to the invention comprises a hyperbranched copolymer, in particular a copolymer of the formula: [ka] The monomers do not include hyperbranched dodecenylsuccinic anhydride, diisopropanolamine, bisdimethylaminopropylamine, etc., having terminal groups of

[0077] The topical compositions according to the invention are in particular skin care formulations, functional formulations and / or hair care formulations, most in particular skin care formulations.

[0078] Examples of skin care formulations are in particular sunscreen formulations, anti-aging formulations, formulations for treating photoaging, body oils, body lotions, body gels, treatment creams, skin protective ointments, moisturizing formulations such as moisturizing gels or moisturizing sprays, facial and / or body moisturizers, and skin whitening formulations.

[0079] Examples of functional formulations are, but are not limited to, cosmetic compositions containing active ingredients such as hormone formulations, vitamin formulations, vegetable extract formulations, anti-aging formulations, and / or antimicrobial (anti-bacterial or anti-fungal) formulations.

[0080] Examples of suitable hair care formulations according to the invention include shampoos, hair conditioners (also called hair rinses), hair finishing compositions, hair tonics, hair regeneration compositions, hair lotions, water wave lotions, hair sprays, hair creams, hair gels, hair oils, hair pomades or hair brilliantines. All of these formulations are thus applied to the hair and scalp for shorter or longer periods of time depending on the actual purpose for which they are used.

[0081] The topical composition according to the invention is advantageously an O / W emulsion, a W / O emulsion and / or a gel.

[0082] Furthermore, the topical compositions according to the invention in the form of O / W emulsions, W / O emulsions and / or gels are skin care formulations intended to protect the skin from the harmful effects of UV radiation, to maintain healthy skin homeostasis and / or to maintain a balance in the skin microflora.

[0083] Preferably, in all embodiments of the present invention, the skin care formulation is a sunscreen formulation.

[0084] Preferably, the sunscreen formulation comprises at least one UV filter. The UV filter may be a liquid or solid UV filter. The UV filter may be a UV-A or UV-B filter. Suitable liquid UV filters absorb light in the range of UVB (280-315 nm) and / or UVA (315-400 nm) and are liquid at ambient temperature (i.e. 25° C.). Such liquid UV filters are well known to those skilled in the art and include in particular cinnamates, such as octyl methoxycinnamate (PARSOL® MCX) and isoamyl methoxycinnamate (Neo Heliopan® E). 1000), salicylates such as homosalate (3,3,5 trimethylcyclohexyl 2-hydroxybenzoate, PARSOL® HMS) and ethylhexyl salicylate (also known as ethylhexyl salicylate, 2 ethylhexyl 2-hydroxybenzoate, PARSOL® EHS), acrylates such as octocrylene (2 ethylhexyl 2-cyano-3,3-diphenylacrylate, PARSOL® 340) and ethyl 2-cyano- 3,3 diphenylacrylate, esters of benzalmalonic acid, in particular dialkyl benzalmalonates such as di(2-ethylhexyl) 4-methoxybenzalmalonate and polysilicone 15 (PARSOL® SLX), dialkyl esters of naphthalates such as diethoxyhexyl 2,6-naphthalate (Corapan® TQ), syringylidene malonates such as diethylhexyl syringylidene malonate (Oxynex® ST liquid), and benzotriazolyl dodecyl p-cresol (Tinoguard® TL), as well as benzophenone-3 and drometrizole trisiloxane.

[0085] Particularly advantageous liquid UV filters are octyl methoxycinnamate, homosalate, ethylhexyl salicylate, octocrylene, diethylhexyl 2,6-naphthalate, diethylhexyl syringylidene malonate, benzotriazolyl dodecyl p-cresol, benzo-phenone-3, drometrizole trisiloxane, polysilicone-15, and mixtures thereof.

[0086] Suitable solid UV filters are those that absorb light in the UVB and / or UVA range and are solid at ambient temperature (i.e. 25° C.). These are in particular solid organic UV filters. Particularly suitable solid UV filters are those from the group consisting of bisethylhexyloxyphenol methoxyphenyl triazine, butyl methoxydibenzoylmethane, methylene bisbenzotriazolyl tetramethylbutylphenol, diethylamino hydroxybenzoyl hexyl benzoate, ethylhexyl triazone, diethylhexyl butamido triazone, and 4-methylbenzylidene camphor.

[0087] The amount of each organic UV filter is preferably in the range of 0.1 to about 10% by weight, preferably in the range of 0.5 to 7.5% by weight, most preferably in the range of 1 to 5% by weight, based on the total weight of the sunscreen formulation.

[0088] In the case of sunscreen compositions, the total amount of organic UV filters depends largely on the targeted UV protection power of the composition and is typically in the range of 1 to 50% by weight, preferably in the range of 5 to 40% by weight, based on the total weight of the sunscreen formulation.

[0089] For example, a sunscreen formulation with SPF15 (SPF=ultraviolet protection factor) contains organic UV filters in a total amount of preferably 4 to 20 mass %, more preferably 7 to 15 mass %, based on the total mass of the sunscreen formulation.

[0090] For example, a sunscreen formulation with SPF 30 contains organic UV filters in a total amount of preferably 10 to 40% by mass, more preferably 15 to 25% by mass, based on the total mass of the sunscreen formulation.

[0091] For example, a sunscreen formulation with SPF50 contains organic UV filters in a total amount of preferably 15 to 50% by mass, more preferably 20 to 40% by mass, based on the total mass of the sunscreen formulation.

[0092] It has been found that the addition of 1,4-di(benzoxazol-2'-yl)benzene and at least one compound selected from the group consisting of hydroxyacetophenone, alkanediol, and benzoic acid or its salt to a topical composition significantly increases the antimicrobial activity. In other words, it has been found that the addition of this synergistic antimicrobial mixture to a composition results in a lower number of microorganisms growing than when 1,4-di(benzoxazol-2'-yl)benzene or a compound selected from the group consisting of hydroxyacetophenone, alkanediol, and benzoic acid or its salt is not used, i.e., when 1,4-di(benzoxazol-2'-yl)benzene or a compound selected from the group consisting of hydroxyacetophenone, alkanediol, and benzoic acid or its salt is used alone. Thus, 1,4-di(benzoxazol-2'-yl)benzene (benzen) provides a synergistic effect on the antimicrobial activity of hydroxyacetophenone, alkanediol, and benzoic acid or its salt, especially in cosmetic compositions.

[0093] Moreover, this antimicrobial effect has been observed to be particularly pronounced in aqueous systems, which is highly advantageous since it is known that it is typically the aqueous phase of a product where microbial growth is most likely to occur.

[0094] The following examples are provided to further illustrate the compositions and effects of the present invention. These examples are illustrative only and are not intended to limit the scope of the invention in any manner.

[0095] [Example] [1. Preparation of 1,4-di(benzoxazol-2'-yl)benzene] A mixture of 702 g of polyphosphoric acid and 4.28 ml of methanesulfonic acid was heated to 90° C. 65 g of terephthalic acid and 107 g of 2-aminophenol were added. The mixture was stirred at 180° C. for 8 hours under an inert atmosphere and then transferred to ice water. The precipitate was filtered and washed with water and acetic acid. The precipitate was dispersed in water, the pH was adjusted to 8.0 with sodium hydroxide, filtered and washed with water. The crude product was suspended in a 3.3:1 mixture of toluene and 1-butanol, stirred at 85° C. for 1 hour, filtered, washed with diethyl ether and dried to obtain coarse particles of solid amorphous 1,4-di(benzoxazol-2′-yl)benzene (hereinafter referred to as DBO).

[0096] [Preparation of 30% by weight aqueous dispersion of 2.1,4-di(benzoxazol-2'-yl)benzene] A suspension of 175 g of the coarse particles, 324 g of water, and 65 g of Green APG 0 810 was then prepared and this suspension was milled in a LabStar laboratory mill using yttrium-stabilized zirconium oxide grinding beads (0.3 mm, Tosoh Ceramic, Japan) for 2 h and cooled in the milling chamber (saturated saline at -12 °C). Removal of the grinding beads yielded a 30% aqueous dispersion of micronized 1,4-di(benzoxazol-2'-yl)benzene (hereafter referred to as DBO aq.) which was used for the antimicrobial testing and formulation outlined below.

[0097] [1. Antimicrobial activity] Antimicrobial efficacy was assessed in a manner similar to the regulatory challenge test (NF EN ISO11930). According to this, mixtures of each active substance outlined below with physiological serum at a NaCl concentration of 0.85% by weight were prepared under sterile conditions. Controls were also prepared under sterile conditions. The controls and mixtures were then dispensed into 96 deep well plates (1.6 ml / well). Wells were filled with each bacterial or fungal strain as outlined below, with 2.5 x 10 5 ~5.6×10 5 cfu / ml, for fungi 1 × 10 4 ~2.5×10 4 Initial contamination was achieved by contaminating wells to a concentration of 0.01 cfu / ml. After contamination, each well was mixed thoroughly to ensure uniform distribution of the microorganisms. Each plate was then incubated at 22°C for 24 hours. 24 hours after contamination, a count of (surviving) bacteria was performed. The average log reduction was then calculated [-log10{(inoculum number) / (sample number)}]. These are shown in Tables 1 to 5.

[0098] [Table 1]

[0099] [Table 2]

[0100] As can be seen from the above table, 1,4-di(benzoxazol-2'-yl)benzene exhibits antimicrobial effects against a wide range of microorganisms and can therefore be used as a preservative enhancer. It is known that the aqueous phase of a product is usually the most susceptible to microbial growth. Therefore, 1,4-di(benzoxazol-2'-yl)benzene is particularly suitable for protecting products that contain an aqueous phase, such as cosmetic compositions in the form of O / W or W / O emulsions, against microbial corrosion and degradation, and therefore for enhancing their preservative power.

[0101] [Table 3]

[0102] As can be seen from Table 2, DBO synergistically enhances the antimicrobial activity of p-hydroxyacetophenone.

[0103] [Table 4]

[0104] As can be seen from Table 3, the combination of DBO and sodium benzoate exhibits synergistic antimicrobial activity.

[0105] [Table 5]

[0106] As can be seen from Table 4, the combination of DBO and 1,3-propanediol exhibits synergistic antimicrobial activity.

[0107] [2. Prescription Examples]

[0108] [Table 6]

[0109] [Table 7]

[0110] [Table 8]

[0111] [Table 9]

[0112]

Table 10

[0113]

Table 11

Claims

1. A topical composition comprising 1,4-di(benzoxazol-2'-yl)benzene and at least one compound selected from the group consisting of hydroxyacetophenones, alkanediols, and benzoic acid or a salt thereof.

2. The topical composition of claim 1, wherein the amount of 1,4-di(benzoxazol-2'-yl)benzene is selected in the range of 1 to 20% by weight, based on the total weight of the composition.

3. The topical composition according to claim 1 or 2, wherein the amount of hydroxyacetophenone is selected in the range of 0.001 to 5% by weight, based on the total weight of the composition.

4. The topical composition according to any one of claims 1 to 3, wherein the amount of the alkanediol is selected in the range of 0.01 to 5% by weight, based on the total weight of the composition.

5. The topical composition according to any one of claims 1 to 4, wherein the amount of benzoic acid or its salt is selected in the range of 0.001 to 6% by weight, based on the total weight of the composition.

6. 6. The topical composition of claim 1, wherein the weight ratio of the 1,4-di(benzoxazol-2'-yl)benzene to the at least one compound selected from the group of hydroxyacetophenones, alkanediols, and benzoic acid or a salt thereof is selected from the range of 50:1 to 1:

10.

7. 7. The topical composition of any one of claims 1 to 6, wherein the hydroxyacetophenone is p-hydroxyacetophenone, the alkanediol is 1,3-propanediol, and the benzoic acid or salt thereof is sodium benzoate.

8. The topical composition according to any one of claims 1 to 7, wherein the composition is an O / W emulsion, a W / O emulsion, or a gel.

9. The topical composition of any one of claims 1 to 8, wherein the composition comprises water and an oil.

10. A topical composition comprising a mixture of 1,4-di(benzoxazol-2'-yl)benzene and at least one compound selected from the group of hydroxyacetophenones, alkanediols, and benzoic acid or a salt thereof as a synergistic antimicrobial mixture for enhancing the shelf life and / or storage stability of the topical composition.

11. 11. The topical composition of claim 10, wherein the hydroxyacetophenone is p-hydroxyacetophenone, the alkanediol is 1,3-propanediol, and the benzoic acid or salt thereof is sodium benzoate.

12. A method for inhibiting or slowing microbial degradation of a topical composition, the method comprising adding to the topical composition an effective amount of 1,4-di(benzoxazol-2'-yl)benzene and at least one compound selected from the group consisting of hydroxyacetophenones, alkanediols, and benzoic acid or a salt thereof.

Citation Information

Patent Citations

  • Cosmetic, dermatological or veterinary compositions for the aseptic treatment of human and animal skin

    JP2000504740A

  • Anti-sun composition comprising at least one insoluble UV-screening agent and at least one hydroxyalkylurea

    JP2006176519A

  • Insoluble organic UV filters and cosmetic use thereof

    WO2002039972A1